Results 101 to 110 of about 500,219 (165)
BackgroundSelf-care interventions, including contraceptive self-injectables such as subcutaneous depot medroxyprogesterone acetate (DMPA-SC), are hypothesized to be empowering to users.
Megan M Lydon +6 more
doaj +1 more source
Finally, PrEP choices! But will clients ever have a choice?
Journal of the International AIDS Society, Volume 28, Issue S2, July 2025.
Kimberly E. Green +4 more
wiley +1 more source
A systematic comparison of implementation strategies at three U.S. clinic settings that expanded access to self-administered injectable contraception [PDF]
OBJECTIVES: To describe experiences and systematically compare three U.S. clinics that initiated or expanded access to depot medroxyprogesterone acetate-subcutaneous (DMPA-SC) for self-administration during the COVID-19 pandemic.
Rafie, Sally +4 more
core +1 more source
GAMBARAN PENGETAHUAN AKSEPTOR KB SUNTIK DMPA TENTANG KONTRASEPSI DMPA DI PUSKESMAS LEYANGAN TAHUN 2020 [PDF]
Kontrasepsi suntik efektif untuk mencegah kehamilan 0,3 kehamilan per 100 perempuan, memiliki sedikit efek samping dan dapat mengurangi risiko infertilitas primer hingga 40%.
Cahyaningrum, Cahyaningrum +1 more
core
Background Self-injectable contraceptives provide individuals the opportunity to prevent pregnancy with a self-controlled method that helps enhance self-care.
Serah Gitome +9 more
doaj +1 more source
Background The low use of self-injectable contraception, coupled with the recognition that many individuals need support beyond training to use self-care technologies successfully, suggests the need for innovative programming.
C Birabwa +13 more
doaj +1 more source
Contraceptive use and decision-making in Guéra, Chad: a mixed-methods study
BackgroundChad has one of the highest maternal mortality ratios in the world, and low modern contraceptive prevalence. Understanding the barriers and influences on women's decision-making around contraceptive use is critical to reducing the unmet ...
Vincent de Paul Allambademel +10 more
doaj +1 more source
Background Although self-injectable subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has demonstrated promise, there are significant barriers in promoting initiation and continued use in low-resource settings.
Grace W. Kimemia +10 more
doaj +1 more source
Contraceptive efficacy and safety of DMPA-SC [PDF]
openaire +1 more source
Access to a full range of contraceptive methods — including user-controlled and self-administered options like self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) supports reproductive autonomy and ensures patients can choose the ...
Aderibigbe, Ifedolapo
core

